机构风向标 | 兴齐眼药(300573)2024年四季度已披露持股减少机构超10家

Group 1 - The core viewpoint of the news is the disclosure of shareholding information for Xingqi Eye Pharmaceutical (300573.SZ) as of April 21, 2025, highlighting the involvement of institutional investors and changes in their holdings [1] - A total of 319 institutional investors disclosed holding shares in Xingqi Eye Pharmaceutical, with a combined holding of 33.143 million shares, representing 18.91% of the total share capital [1] - The top ten institutional investors collectively hold 10.85% of the shares, with a decrease of 4.93 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, there was an increase in holdings from one public fund, Dacheng CSI 500 Index Enhanced A, while 12 public funds reduced their holdings, with a decrease rate of 1.35% [2] - A total of 290 new public funds were disclosed this period, including Southern CSI 500 ETF and Huaxin ChiNext 50 ETF [2] - From the pension fund perspective, one pension fund, the Basic Pension Insurance Fund 160222 Combination, reduced its holdings by 1.0% [2] - One foreign fund, Hong Kong Central Clearing Limited, also reduced its holdings by 0.62% [2]